Results 121 to 130 of about 5,642 (192)

2-Pyridone-assisted palladium-catalyzed regioselective arylation of naphthamides. [PDF]

RSC Adv
Prajapati J, Chatterjee S.
europepmc   +1 more source

Crystal structure of 3-cyano-4-(4-chlorophenyl)-5,6-dimethyl-2(1H)- pyridone, C14H11ClN2O

Zeitschrift für Kristallographie - New Crystal Structures, 2007
Balalaie Saeed, Hashemi Mohammed M., Khezri Seyed H., Rominger Frank   +3 more
doaj   +1 more source

Identification of potential NAD-related biomarkers of recurrent miscarriage risk. [PDF]

Hum Reprod
Cuny H, Shand AW, Goth J, Sheng DZ, Tossey T, Martin EMMA, Sipka A, Aleshin O, Schneuer FJ, Nassar N, Dunwoodie SL.   +10 more
europepmc   +1 more source

Endoperoxide delivered singlet oxygen: the future of PDT, without light or oxygen. [PDF]

RSC Med Chem
Wang W, Wang L, Sun R, Qian X, Liu Z, Akkaya EU.   +5 more
europepmc   +1 more source

From Mono-<i>N</i>-Protected Amino Acids to Pyridones: A Decade of Evolution of Bifunctional Ligands for Pd(II)-Catalyzed C-H Activation. [PDF]

Acc Chem Res
Li YH, Ouyang Y, Yan JL, Chekshin N, Yu JQ.   +4 more
europepmc   +1 more source

Practical Ligand-Enabled C-H Halogenation of (Hetero)Benzoic and (Hetero)Aryl Acetic Acids. [PDF]

J Am Chem Soc
Zhao H, Li Z, Zhu X, Yu JQ.
europepmc   +1 more source

Making Sense of Heteroatom Effects in π-π Interactions. [PDF]

J Am Chem Soc
Do KU, Conner AV, Wheeler SE.
europepmc   +1 more source

Optimization of 4-Amino-2-Pyridone Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9: Integrating Structure-Activity and Structure-Metabolism Relationships. [PDF]

ChemMedChem
Giannessi L, Lupo MG, Ugolotti M, Papotti B, Mattina B, Martina MG, Demurtas A, Padula C, Nicoli S, Crescenzio M, Ferri N, Zimetti F, Radi M.   +12 more
europepmc   +1 more source

New analogs of 5-substituted-2(1<i>H</i>)-pyridone containing of natural amino acids as potential drugs in idiopathic pulmonary fibrosis. Investigation <i>in silico</i> and preliminary <i>in vitro</i>. [PDF]

Acta Biochim Pol
Dzierzbicka K, Skrzypkowska M, Gensicka-Kowalewska M, Daśko M, Słomiński B.   +4 more
europepmc   +1 more source

Therapeutic horizons in the development of PROTAC-based EZH2 inhibitors: recent achievements, comparative analysis, and future perspectives. [PDF]

RSC Adv
S Abulkhair H.
europepmc   +1 more source